Wednesday, July 8, 2026

biotech · Metastatic Non-Small Cell Lung Cancer · NSCLC · AVBP

ArriVent BioPharma

ArriVent BioPharma clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Newtown Square, USA HQ
75 Employees
Public company Type
AVBP · NYSE Ticker
Company details
Status
Public
HQ
Newtown Square, USA
Employees
75
Programs
7
Drugs
4
Patents
0
Intelligence · Clinical Programs

ArriVent BioPharma projects

0 ClinicalTrials.gov programs sponsored by ArriVent BioPharma.

ArriVent BioPharma has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

No programs matched

Try a different phase filter or check back as we index more trials.

Frequently asked questions

How many clinical projects does ArriVent BioPharma have?

0 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.